Gonadotropin-releasing hormone antagonist versus progestin for the prevention of premature luteinising hormone surges in poor responders undergoing in vitro fertilisation treatment: study protocol for a randomised controlled trial

DiscussionTo our knowledge, this is the first RCT to examine the efficacy of administering progestin orally to block LH surges and premature ovulation compared with the GnRH antagonist protocols in poor responders undergoing IVF treatment.Trial registrationwww.chictr.org.cn.ChiCTR-IPR-17010906. Registered on 18 March 2017.

http://link.springer.com/10.1186/s13063-018-2850-x

Source: Trials - August 22, 2018 Category: Research Source Type: clinical trials